GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zentiva SA (BSE:SCD) » Definitions » ROE % Adjusted to Book Value

Zentiva (BSE:SCD) ROE % Adjusted to Book Value : 8.53% (As of Sep. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Zentiva ROE % Adjusted to Book Value?

Zentiva's ROE % for the quarter that ended in Sep. 2024 was 17.31%. Zentiva's PB Ratio for the quarter that ended in Sep. 2024 was 2.03. Zentiva's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 8.53%.


Zentiva ROE % Adjusted to Book Value Historical Data

The historical data trend for Zentiva's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentiva ROE % Adjusted to Book Value Chart

Zentiva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.07 3.44 6.61 7.79 10.29

Zentiva Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.60 13.89 14.73 11.71 8.53

Competitive Comparison of Zentiva's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Zentiva's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zentiva's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zentiva's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zentiva's ROE % Adjusted to Book Value falls into.



Zentiva ROE % Adjusted to Book Value Calculation

Zentiva's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=17.59% / 1.71
=10.29%

Zentiva's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=17.31% / 2.03
=8.53%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zentiva ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Zentiva's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Zentiva Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.

Zentiva Headlines

From GuruFocus